Coronary angioplasty using the everolimus-eluting stent

DEVICE2 trials

Sponsors

Fundación Médica para la Investigación y Desarrollo en el Area Cardiovascular

Conditions

In-Stent RestenosisIn-stent Restenosis

Phase 4

RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)

Fundación Médica para la Investigación y Desarrollo en el Area CardiovascularIn-Stent Restenosis

Start: 2010-01-31Updated: 2012-02-27

RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)

Fundación Médica para la Investigación y Desarrollo en el Area CardiovascularIn-stent Restenosis

Start: 2010-01-31Target: 310Updated: 2011-06-27

Related Papers

Long-Term Results of Bioresorbable Vascular Scaffolds in Patients With In-Stent Restenosis: The RIBS VI Study.

2024-08-016 citations

3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents.

2018-05-0177 citations

Usefulness of Drug-Eluting Balloons for Bare-Metal and Drug-Eluting In-Stent Restenosis (from the RIBS IV and V Randomized Trials).

2017-01-057 citations

Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis

Circulation Cardiovascular Interventions2016-07-0126 citations

Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial.

2016-06-2051 citations

A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents: The RIBS IV Randomized Clinical Trial.

2015-07-01227 citations

Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)

EuroIntervention2015-07-0110 citations

RIBS IV: EES Superior to Paclitaxel-Eluting Balloon for Treating DES Restenosis

MD Conference Express2014-10-01

A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).

2014-01-08201 citations